Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 111 OC10.8 | DOI: 10.1530/endoabs.111.OC10.8

BSPED2025 Oral Communications Endocrine Oral Communications 4 (8 abstracts)

Behind the glucose dip: a retrospective review of paediatric ketotic hypoglycaemia and evolving management approaches

Chern Tan 1 , Sameera Hannah Auckburally 1 , Indraneel Banerjee 1,2 & Arunabha Ghosh 1


1Royal Manchester Children’s Hospital, Manchester, United Kingdom; 2University of Manchester, Manchester, United Kingdom
*Chern Tan and Sameera Hannah Auckburrally are joint first authors


Introduction: Ketotic hypoglycemia (KH), a common cause of hypoglycaemia in young children, is typically a diagnosis of exclusion. Given the increase in referrals of recurrent KH to paediatric endocrine and metabolic services, we aimed to examine the clinical outcomes of KH referrals in a large children’s hospital in the UK.

Methods: Data were collected retrospectively for all patients with KH known to either the paediatric endocrinology or metabolic departments between 2019 and 2024.

Results: Over a 6-year period, a total of 165 children (53% female) with KH were reviewed by tertiary services. Of these, 126 children (76%) were reviewed by the metabolic team, and 39 (24%) by the endocrine team. Median age at referral was 3 years (range: 9 months - 15 years) whilst the reported age of symptom onset ranged from 3 days to 9 years. Neurodevelopmental disorders (13.3%) was a common comorbidity with KH. However, the presence of comorbidities was not associated with an increased risk of recurrence (odds ratio: 0.98 [0.41-2.36]). In 44 children with recurrent hypoglycaemia, gene panel testing identified two children with metabolic diagnoses (phosphoglucomutase 1 deficiency and dihydropyrimidine dehydrogenase deficiency), while 5 children had variants of unknown significance in the glycogen storage disorder IX and monocarboxylate transporter 1 genes. Hypoglycaemia resolution occurred in 83% of endocrine patients by 8 years of age and 95% of metabolic patients by 7 years of age. Short-term continuous glucose monitoring (CGM) was used in 25/39 (endocrine) and 28/126 (metabolic) patients to demonstrate normoglycaemia, providing reassurance prior to discharge. Endocrine patients remained under follow-up for a mean duration of 16 months (range: 1 - 78 months), compared to 48 months (range: 0 – 177 months) for metabolic patients, reflecting significant workload volumes for both services.

Conclusion: The study highlights the clinical heterogeneity and favourable outcomes of ketotic hypoglycaemia in a large cohort of patients referred to tertiary services. Although infrequent, it is important to investigate inborn errors in metabolism in those with persistent and recurrent ketotic hypoglycaemia.

Volume 111

52nd Annual Meeting of the British Society for Paediatric Endocrinology and Diabetes

Sheffield, UK
12 Nov 2025 - 14 Nov 2025

British Society for Paediatric Endocrinology and Diabetes 

Browse other volumes

Article tools

My recent searches

No recent searches